095700 — Genexine Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Genexine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS/A	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,714	27,796	21,942	64,482	32,078
Net Total Accounts Receivable
Net Total Receivables	8,345	2,440	13,779	16,642	6,642
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20,646	57,274	52,384	92,160	46,936
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	71,856	111,969	110,932	114,209	118,938
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	596,908	636,865	388,781	376,587	345,042
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40,217	59,154	78,933	54,526	53,992
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	61,303	122,937	116,140	79,965	83,361
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	535,605	513,928	272,641	296,622	261,681
Total Liabilities & Shareholders' Equity	596,908	636,865	388,781	376,587	345,042
Total Common Shares Outstanding